StockData
BioCorRx Inc. logo

BioCorRx Inc. (BICX) stock

BICXOTCServices-Specialty Outpatient Facilities, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$0.25+0.00 (0.00%)

Close on Oct 19, 2026Market cap $7.30MP/E –Yield –

BioCorRx net income

Net income is the profit left for shareholders after every expense, interest and tax.

BioCorRx's net income for the twelve months ending Jun 30, 2026 was -$3.16M. For fiscal 2025 it was -$3.44M. The highest annual figure on record is -$13.20K in fiscal 2009.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$3.44M–
FY2024Dec 31, 2024-$5.11M–
FY2023Dec 31, 2023-$3.77M–
FY2022Dec 31, 2022-$4.38M–
FY2021Dec 31, 2021-$5.21M–
FY2020Dec 31, 2020-$3.51M–
FY2019Dec 31, 2019-$6.05M–
FY2018Dec 31, 2018-$6.58M–
FY2017Dec 31, 2017-$29.71M–
FY2016Dec 31, 2016-$5.90M–
FY2015Dec 31, 2015-$4.67M–
FY2014Dec 31, 2014-$3.13M–
FY2013Dec 31, 2013-$3.84M–
FY2012Dec 31, 2012-$885.81K–
FY2011Dec 31, 2011-$408.97K–
FY2010Dec 31, 2010-$154.59K–
FY2009Dec 31, 2009-$13.20K–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$964.77K–
Q1 FY2026Mar 31, 2026-$831.23K–
Q4 FY2025Dec 31, 2025$552.56K–
Q3 FY2025Sep 30, 2025-$1.92M–
Q2 FY2025Jun 30, 2025-$1.23M–
Q1 FY2025Mar 31, 2025-$841.41K–
Q4 FY2024Dec 31, 2024-$1.16M–
Q3 FY2024Sep 30, 2024-$1.49M–
Q2 FY2024Jun 30, 2024-$1.22M–
Q1 FY2024Mar 31, 2024-$1.24M–
Q4 FY2023Dec 31, 2023-$969.01K–
Q3 FY2023Sep 30, 2023-$867.35K–
Q2 FY2023Jun 30, 2023-$923.55K–
Q1 FY2023Mar 31, 2023-$1.01M–
Q1 FY2022Mar 31, 2022-$944.99K–
Q2 FY2021Sep 30, 2021-$2.43M–
Q1 FY2021Mar 31, 2021-$1.58M–
Q4 FY2020Dec 31, 2020-$904.67K–
Q3 FY2020Sep 30, 2020-$785.17K–
Q2 FY2020Jun 30, 2020-$738.48K–
Q1 FY2020Mar 31, 2020-$1.08M–
Q4 FY2019Dec 31, 2019-$1.20M–
Q3 FY2019Sep 30, 2019-$1.03M–
Q2 FY2019Jun 30, 2019-$2.04M–
Q1 FY2019Mar 31, 2019-$1.77M–
Q4 FY2018Dec 31, 2018-$2.47M–
Q3 FY2018Sep 30, 2018-$1.89M–
Q2 FY2018Jun 30, 2018-$1.22M-110.8%
Q1 FY2018Mar 31, 2018-$1.00M–
Q4 FY2017Dec 31, 2017-$1.57M–
Q3 FY2017Sep 30, 2017-$1.10M–
Q2 FY2017Jun 30, 2017$11.30M–
Q1 FY2017Mar 31, 2017-$38.34M–
Q4 FY2016Dec 31, 2016-$1.69M-31594.8%
Q3 FY2016Sep 30, 2016-$2.61M–
Q2 FY2016Jun 30, 2016-$1.07M–
Q1 FY2016Mar 31, 2016-$528.59K–
Q4 FY2015Dec 31, 2015$5.38K–

More BioCorRx figures

See a number that looks wrong?